Fr. 51.50

Biotechnology in Japan

English · Paperback / Softback

Will be released 19.01.2026

Description

Read more










In the early 1980s, biotechnology caused worldwide excitement as a high technology with almost unlimited potential in science, medicine, and industry. It not only allowed the manufacture of traditional products more quickly and inexpensively, but also offered the possibility of synthesizing valuable materials anew. All this made it very attractive to Japanese policymakers, who 'targeted' it as a high priority area for economic growth.
Originally published in 1989, Biotechnology in Japan is the first published in English to analyse the Japanese effort to promote the new biotechnology industries. The author examines the strategies used for developing biotechnology in Japan and looks at the active role of government in a field in which the Japanese rapidly became the world leaders. Focusing on the making and implementation of biotechnology policy, he considers the relationship between the public and the private sector, and makes use of different political constructs to analyse Japan's complex and unique balance between competitive market forces and collective interest.


List of contents










Introduction 1. Understanding Japanese policy-making with the Triple N Synthesis 2. Definition of biotechnology 3. Building a high tech society in Japan 4. Strategies for developing biotechnology in Japan 5. Implementation of biotechnology policy ­- strategy for its promotion Conclusion: The Triple N Synthesis


About the author










Malcolm V. Brock is a former Rhodes Scholar, with degrees in both science and oriental studies.


Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.